FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Conroy et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d70f295413bc3de5ab3526 — DOI: https://doi.org/10.1056/nejmoa1011923

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study· 2005 · 239 citations
2. Toxicity and response criteria of the Eastern Cooperative Oncology Group· 1982 · 11,560 citations
3. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary· 2009 · 1,013 citations
4. New Guidelines to Evaluate the Response to Treatment in Solid Tumors· 2000 · 15,708 citations
5. Cancer Statistics, 2010· 2010 · 12,610 citations